Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival
Authors:
Open Access
- 10 October 2005
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (12) , 1049-1052
Abstract
Allograft dendritic cell (DC) content has been identified as a predictor of relapse and event-free survival after allogeneic bone marrow transplantation. However, the prognostic importance of DCs has not been evaluated in the setting of autologous hematopoietic stem cell transplantation (HSCT). We prospectively determined pre-transplant and post transplant DC levels, including DC1 and DC2 subset levels, in 53 patients with diffuse large B-cell non-Hodgkin's lymphoma (DLBC NHL) undergoing autologous HSCT. Pre-transplant DCs were measured in the collected stem cell products and were therefore indicative of cell numbers infused directly into patients; post transplant analysis of DCs was performed on the peripheral blood of patients 6 weeks after the infusion of autologous stem cells. Higher pre-transplant levels of DC1 cells and total DCs were significantly associated with improved survival. Similarly, greater post transplant levels of total DCs and both subsets were significantly associated with survival. These findings suggest a relationship between DC reconstitution and survival following autologous HSCT for DLBC NHL. Strategies to increase autograft DC content or accelerate DC recovery after autologous HSCT might improve outcomes in this setting.Keywords
This publication has 15 references indexed in Scilit:
- Manipulating dendritic cell biology for the active immunotherapy of cancerBlood, 2004
- Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaBone Marrow Transplantation, 2003
- Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF aloneBone Marrow Transplantation, 2003
- Dendritic cell recovery after autologous stem cell transplantationBone Marrow Transplantation, 2002
- Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?JNCI: Journal of the National Cancer Institute, 2002
- Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantationBlood, 2001
- Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer TherapyJournal of Clinical Oncology, 2000
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patientsCancer Immunology, Immunotherapy, 1998
- CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.Journal of Experimental Medicine, 1996